User:Charli Barbet/Sandbox

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 77: Line 77:
Grb2 protein is especially involved in the setting up of cellular oncognesis in prostate, colon and lung cancers. This role is mainly due to its essential role in signal transduction in the MAP kinase pathway known to induce mitosis.
Grb2 protein is especially involved in the setting up of cellular oncognesis in prostate, colon and lung cancers. This role is mainly due to its essential role in signal transduction in the MAP kinase pathway known to induce mitosis.
In this pathway, GrbS binds to the oncogenic protein SOS under its monomeric form. Yet SOS can also be found in its dimeric form in the cell.
In this pathway, GrbS binds to the oncogenic protein SOS under its monomeric form. Yet SOS can also be found in its dimeric form in the cell.
-
Dimerization of Grb2 is dependent upon several factors like the phosphorylation of tyrosine 160 or the binding of ligand on the SH2 domain of the same protein. Mainly, phosphorylation induce the dissociation of the Grb2 dimer induce an increase in the MAP kinase pathway activation by the binding of SOS.
+
Dimerization of Grb2 is dependent upon several factors like the phosphorylation of <scene name='75/750264/Y160/1'>tyrosine 160</scene> or the binding of ligand on the SH2 domain of the same protein. Mainly, phosphorylation induce the dissociation of the Grb2 dimer induce an increase in the MAP kinase pathway activation by the binding of SOS. The phosphorylated state of <scene name='75/750264/Y160/1'>Y160</scene> has been discovered in severa pre-metastatis cancers. This highly suggest that pY160 could be a oncogenic marker in humans. A new therapeutic way could therefore be considered by stabilizing Grb2 in its dimeric form. This could be achieve with a protein acting as an irreversible cross-link at the interface between the 2 units.
-
The phosphorylated state of Y160 has been discovered in severa pre-metastatis cancers. This highly suggest that pY160 could be a oncogenic marker in humans.
+
-
A new therapeutic way could therefore be considered by stabilizing Grb2 in its dimeric form. This could be achieve with a protein acting as an irreversible cross-link at the interface between the 2 units.
+
<br style="clear:both" />
<br style="clear:both" />

Revision as of 08:18, 13 January 2017

Grb2 (1gri)

Caption for this structure

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

Charli Barbet

Personal tools